Business Strategy Analysis of PT Kalbe Farma Tbk Using Strategic Management Approach
DOI:
https://doi.org/10.38035/dijefa.v6i4.5068Keywords:
strategic analysis, PT Kalbe Farma Tbk, pharmaceutical industry, product development, market developmentAbstract
This article aims to analyze the business strategy of PT Kalbe Farma Tbk, the largest integrated pharmaceutical company in Indonesia, in responding to the dynamics of the competitive and evolving pharmaceutical industry. This study applies a qualitative approach with a case study method based on secondary data, including company annual reports and strategic management literature. The analytical tools used include PESTEL, Porter’s Five Forces, Product Life Cycle, SWOT, Value Chain, and strategic matrices such as SWOT, SPACE, IE, BCG, and the Grand Strategy Matrix. The results show that Kalbe’s strengths lie in brand reputation, product diversification, and an extensive distribution network, with opportunities arising from digitalization trends and increased public health awareness. The recommended strategies are product development, market development, and forward integration. These strategies are deemed most appropriate based on the QSPM results and are expected to help Kalbe maintain its market leadership while achieving sustainable international expansion.
References
Alodokter. (2022, December 12). 45% of Indonesians still trust herbal medicine more than modern medicine. https://www.alodokter.com/45-masyarakat-indonesia-masih-lebih-percaya-obat-herbal-dibanding-obat-modern
Anwar, S. (2024, January 15). Industrial market structure & the impact of government regulations on the pharmaceutical industry. Kompasiana. https://www.kompasiana.com/syaifulanwar2876/66e83502ed64152da10afa73/struktur-pasar-industri-7-dampak-regulasi-pemerintah-terhadap-industri-farmasi
Binariks. (2023, October 16). Digital transformation in pharma: Overview, benefits & examples. https://binariks.com/blog/digital-transformation-in-pharma/
Bisnis Espos. (2024, March 6). Supporting cancer treatment, Kalbe builds radiopharmaceutical production facility. https://bisnis.espos.id/dukung-penanganan-kanker-kalbe-bangun-konstruksi-radiofarmaka-1854958
BPJS Kesehatan. (2024). Achievements and performance evaluation of the JKN program in 2023. https://web.bpjs-kesehatan.go.id/uploads/information/05072024032036-d0e43b7b-4628-4963-8cb4-a2104605a2e6.pdf
Central Bureau of Statistics. (2024). Indonesia's economy in the first quarter of 2024 grew by 5.11 percent (y-on-y) and contracted by 0.83 percent (q-to-q). https://www.bps.go.id/id/pressrelease/2024/05/06/2380/ekonomi-indonesia-triwulan-i-2024-tumbuh-5-11-persen--y-on-y--dan-ekonomi-indonesia-triwulan-i-2024-terkontraksi-0-83-persen--q-to-q--.html
Chen, Z., Zheng, L., Peng, M. Y.-P., & Shao, L. (2022). How do MNEs shape their international strategic alliances to facilitate higher alliance performance? Absorptive capacity as an antecedent. Frontiers in Psychology, 13, 955117. https://doi.org/10.3389/fpsyg.2022.955117
CNBC Indonesia. (2024, June 14). [Video] The anxiety of the pharmaceutical and medical devices industry facing the weakening rupiah. https://www.cnbcindonesia.com/market/20240614162330-19-546757/video-kecemasan-industri-farmasi-alkes-hadapi-pelemahan-rupiah
David, F. R., David, F. R., & David, M. E. (2023). Strategic Management: A Competitive Advantage Approach, Concepts and Cases (17th ed.). Pearson Education.
Fierce Pharma. (2024, May 14). Indonesia's Kalbe eyes Singapore, Thailand, ASEAN trade bloc ahead. https://www.fiercepharma.com/regulatory/indonesia-s-kalbe-eyes-singapore-thailand-asean-trade-bloc-ahead
Food and Drug Supervisory Agency. (2023, October 23). BPOM grants NIE to Efesa as a biopharmaceutical product innovation in the world. https://www.pom.go.id/berita/bpom-berikan-nie-untuk-efesa-sebagai-inovasi-produk-biopharmaceutical-di-dunia
Gadjah Mada University. (2016, November 23). BPJS Kesehatan significantly influences the pharmaceutical industry. https://ugm.ac.id/id/berita/11045-bpjs-kesehatan-pengaruhi-industri-farmasi-secara-signifikan
Ing, L. Y., Fukunaga, Y., & Isono, I. (2021). Chapter 1: RCEP – Challenges and opportunities. In L. Y. Ing (Ed.), Regional Comprehensive Economic Partnership: Challenges and opportunities for ASEAN (pp. 1–16). Economic Research Institute for ASEAN and East Asia (ERIA). https://www.eria.org/uploads/5_ch_1-RCEP-Challenges-and-Opportunities1.pdf
Kashuri, M., & Tisiyanto, P. D. (2024). The role of BPOM in improving the investment climate for natural medicines, health supplements, and cosmetics. Indonesian Journal of Economics and Public Policy, 11(2), 131–138.
Kompas.id. (2024, June 20). BI decides to keep the benchmark interest rate at 6.25 percent. https://www.kompas.id/baca/ekonomi/2024/06/20/bi-putuskan-suku-bunga-acuan-tetap-625-persen
Kontan. (2024, February 15). The potential of the product market to improve the quality of life of the elderly needs to be encouraged. https://industri.kontan.co.id/news/potensi-pasar-produk-untuk-tingkatkan-kualitas-hidup-lansia-perlu-didorong
Kopi Netizen. (2023, December 28). Encouraging green investment through sustainability reports. https://kopinetizen.com/mendorong-investasi-hijau- melalui-sustainability-report/
Kotler, P. (1965). Exploit the product life cycle. Universitas Dian Nuswantoro Repository. https://repository.dinus.ac.id/docs/ajar/Exploit_the_Product_Life_Cycle.pdf
Krisnadi, G. (2024, February 14). Import dependence threatens the pharmaceutical sector, risk identification becomes a strategy. Kumparan. https://kumparan.com/gidionkrisnadi/ketergantungan-impor-mengancam-sektor-farmasi-identifikasi-risiko-jadi-strategi-22X3ljIxTVZ/4
Laboratorios Rubio. (n.d.). OTC & food supplements: Increasing health-conscious lifestyles. https://www.laboratoriosrubio.com/en/otc-food-supplement/#:~:text=Increasing%20Conscious%20Lifestyle,Connecting%20Brain%20Health%20and%20Intestines
Liputan6.com. (2022, November 21). Profile of PT Kalbe Farma: History and its products. https://www.liputan6.com/hot/read/5149395/profil-pt-kalbe-farma-sejarah-dan-produk-produknya
McKinsey & Company. (2021). The future of healthcare in Asia: Digital health ecosystems. https://www.mckinsey.com/industries/healthcare/our-insights/the-future-of-healthcare-in-asia-digital-health-ecosystems
Microsoft. (n.d.). What is a data leak? https://www.microsoft.com/id-id/security/business/security-101/what-is-a-data-leak
Ministry of Environment and Forestry. (2021). Regulation of the Minister of Environment and Forestry Number 6 of 2021 concerning Criteria and Procedures for Determining the Status of Essential Ecosystem Functions. https://peraturan.bpk.go.id/Details/211000/permen-lhk-no-6-tahun-2021
Ministry of Health of the Republic of Indonesia. (2023). Policy recommendations: Analyzing drug and medical device programs and policies. https://simplek.bkpk.kemkes.go.id/storage/repositories/Rekomendasi%20Kebijakan%20Mengurai%20Program%20dan%20Kebijakan%20Obat%20dan%20Alat%20Kesehatan%20New.pdf
Ministry of Health of the Republic of Indonesia. (n.d.). National Health Insurance Program (JKN). https://www.badankebijakan.kemkes.go.id/program-jaminan-kesehatan-nasional-jkn/
Ministry of Industry. (2024, March 12). The Ministry of Industry continues to realize independence and import substitution for the pharmaceutical industry. Kontan Press Release. https://pressrelease.kontan.co.id/release/kemenperin-terus-wujudkan-kemandirian-dan-substitusi-impor-industri-farmasi?page=all
NutraIngredients-Asia. (2024, February 7). Cracking Indonesia's supplement market with new formats, retail channels and digital power: Exclusive analysis. https://www.nutraingredients-asia.com/Article/2024/02/07/Cracking-Indonesia-s-supplement-market-with-new-formats-retail-channels-and-digital-power-Exclusive-analysis
Organization for Economic Co-operation and Development (OECD). (2010). The economic impact of export restrictions on raw materials. https://www.oecd.org/content/dam/oecd/en/publications/reports/2010/11/the-economic-impact-of-export-restrictions-on-raw-materials_g1g11e10/9789264096448-en.pdf
PermataBank. (2024, June). Monthly industry report – Pharmaceutical industry. https://www.permatabank.com/sites/default/files/2024-08/Monthly%20Industry%20Report%20-%20Pharmaceutical%20Industry%20-%20Jun%202024.pdf
PT Darya-Varia Laboratoria Tbk. (2024). Annual report 2023. https://www.darya-varia.com/
PT Kalbe Farma Tbk. (2024a). Annual Report 2023. https://www.kalbe.co.id/api-content/File/GetFile/Annual%20Report%20KLBF%202023%20.pdf
PT Kalbe Farma Tbk. (2024b). Sustainability Report 2023. https://www.kalbe.co.id/api-content/File/GetFile/KALBE%20SR%202023-web%20ver.pdf
PT Phapros Tbk. (2024). Integrated annual report 2023. https://www.phapros.co.id/
PwC Indonesia. (2023, February 28). Technology drives digital acceleration in Indonesia's health sector. https://www.pwc.com/id/en/media-centre/press-release/2023/indonesian/teknologi-dorong-akselerasi-digital-di-sektor-kesehatan-indonesia.html
PwC. (2024). Voice of the consumer survey 2024 – Asia Pacific. https://www.pwc.com/gx/en/about/pwc-asia-pacific/voice-of-the-consumer-survey-2024-asia-pacific.html
Regulation of the Minister of Defense of the Republic of Indonesia. (2014). Regulation of the Minister of Defense of the Republic of Indonesia Number 20 of 2014 concerning Guidelines for the Government Internal Control System (SPIP) within the Ministry of Defense (BN 874-2014). https://www.kemhan.go.id/itjen/wp-content/uploads/2017/03/bn874-2014.pdf
Regulatory Affairs Professionals Society. (2008, November 1). Emerging markets: The ASEAN harmonization scheme. https://www.raps.org/News-and-Articles/News-Articles/2008/11/Emerging-Markets-The-ASEAN-Harmonization-Scheme
UNDP Indonesia. (2024). Sustainable Development Goals (SDGs). United Nations Development Programme. https://www.undp.org/indonesia/sustainable-development-goals
World Bank. (2024, December). IEP December 2024 – Presentation Part A [PowerPoint slides]. https://thedocs.worldbank.org/en/doc/39c0779d206af32077562e91bac70ea7-0070012024/related/IEP-Dec-2024-Presentation-Part-A.pdf
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Annisa Mahdia Wati, Werner R. Murhadi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish their manuscripts in this journal agree to the following conditions:
- The copyright on each article belongs to the author(s).
- The author acknowledges that the Dinasti International Journal of Economics, Finance & Accounting (DIJEFA) has the right to be the first to publish with a Creative Commons Attribution 4.0 International license (Attribution 4.0 International (CC BY 4.0).
- Authors can submit articles separately, arrange for the non-exclusive distribution of manuscripts that have been published in this journal into other versions (e.g., sent to the author's institutional repository, publication into books, etc.), by acknowledging that the manuscript has been published for the first time in the Dinasti International Journal of Economics, Finance & Accounting (DIJEFA).
